References
- Datta NR, Ordóñez SG, Gaipl US, Paulides MM, Crezee H, Gellermann J, et al. Local hyperthermia combined with radiotherapy and/or chemotherapy: Recent advances and promises for the future. Cancer Treat Rev 2015;41:742–53. doi: 10.1016/j.ctrv.2015.05.009
- Shoji H, Motegi M, Osawa K, Okonogi N, Andou Y, Asao T, et al. Does standardization of radiofrequency hyperthermia benefit patients with malignancies? Ann Cancer Res Ther 2014;22:28–35
- Hiraoka M, Jo S, Akuta K, Nishimura Y, Takahashi M, Abe M. Radiofrequency capacitive hyperthermia for deep-seated tumors II. Effect of thermoradiotherapy. Cancer 1987;60:128–35
- Lee CK, Song CW, Rhee JG, Foy JA, Levitt SH. Clinical experience using 8 MHz radiofrequency capacitive hyperthermia in combination with radiotherapy: Results of a phase I/II study. Int J Radiat Oncol Biol Phys 1995;32:733–45
- Wust P, Stahl H, Löffel J, Seebass M, Riess H, Felix R. Clinical, physiological and anatomical determinants for radiofrequency hyperthermia. Int J Hyperthermia 1995;11:151–67
- Van der Zee J, Van der Holt B, Rietveld PJ, Helle PA, Wijnmaalen AJ, van Putten WL, et al. Reirradiation combined with hyperthermia in recurrent breast cancer results in a worthwhile local palliation. Br J Cancer 1999;79:483–90
- Kok HP, van Haaren PM, van de Kamer JB, Zum Vörde Sive Vörding PJ, Wiersma J, Hulshof MC, et al. Prospective treatment planning to improve locoregional hyperthermia for oesophageal cancer. Int J Hyperthermia 2006;22:375–89
- Wiersma J, Van Wieringen N, Crezee H, Van Dijk JD. Delineation of potential hot spots for hyperthermia treatment planning optimisation. Int J Hyperthermia 2007;23:287–301
- Van der Zee J, Gonzalez Gonzalez D, Van Rhoon GC, Van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000;355(9210):1119–25
- Van Rhoon GC, Van Der Heuvel DJ, Ameziane A, Rietveld PJ, Volenec K, Van Der Zee J. Characterization of the SAR distribution of the Sigma-60 applicator for regional hyperthermia using a Schottky diode sheet. Int J Hyperthermia 2003;19:642–54
- van der Wal E, Franckena M, Wielheesen DH, van der Zee J, van Rhoon GC. Steering in locoregional deep hyperthermia: Evaluation of common practice with 3D-planning. Int J Hyperthermia 2008;24:682–93
- de Bruijne M, Van der Zee J, Ameziane A, Van Rhoon GC. Quality control of superficial hyperthermia by treatment evaluation. Int J Hyperthermia 2011;27:199–213
- Linthorst M, Drizdal T, Joosten H, van Rhoon GC, van der Zee J. Procedure for creating a three-dimensional (3D) model for superficial hyperthermia treatment planning. Strahlenther Onkol 2011;187:835–41
- Canters RAM, Franckena M, van der Zee J, van Rhoon GC. Optimizing deep hyperthermia treatments: Are locations of patient pain complaints correlated with modelled specific absorption rate (SAR), of which distributions of the Sigma-60 applicator are in good agreement with theoretically expected values, peak locations? Phys Med Biol 2011;56:439–51
- Canters RAM, Paulides MM, Franckena MF, van der Zee J, van Rhoon GC. Implementation of treatment planning in the routine clinical procedure of regional hyperthermia treatment of cervical cancer: An overview and the Rotterdam experience. Int J Hyperthermia 2012;28:570–81